// App-Quantinova.ai

3764 : Trabectedin activity in patient-derived mesothelioma xenografts

Researchers

Presenter

  • Simonetta Andrea Licandro

Principal Investigators

  • Roberta Frapolli

  • Ezia Bello

  • Roberta Libener

  • Sara Orecchia

  • Federica Grosso

  • Maurizio DIncalci

Medical Centers

  • Istituto Ricerche Farmacologiche "Mario Negri", Milan, Italy

  • ASO SS Antonio e Biagio e C Arrigo, Alessandria, Italy.

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Malignant pleural mesothelioma

  • Gynaecological cancer

  • Mesothelioma

  • Sarcoma

  • Solid malignancies

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • N/A

Drug/Treatment

  • Trabectedin

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved